Overpriced Antibiotics Seized In Armoor, Nizamabad By DCA

Hyderabad: The TS Drugs Control Administration seized overpriced antibiotics from a pharma firm in Armoor in Nizamabad district. TS DCA Director-General V.B. Kamalasan Reddy said that the product the meropenem injection IP 1 g, brand name Donem, was priced at Rs 1,899 per vial, against the Rs 952.68 set by the Centre’s National Pharmaceutical Pricing Authority (NPPA).

However, the government has fixed a ceiling price of Rs 952 for 1g vial of the said injection. “Maximum Retail Price, including a GST of 12 per cent, should not exceed Rs 1,067 for a 1 g vial of Donem Injection,” DCA said in an official statement.

As per the rules, the maximum retain price including GST of 12 per cent should not be more than Rs 1,067. The higher price was mentioned on the label of the drug manufactured by Doctor’s Life Sciences (India) Ltd in PR Palem Village, Kovur mandal, SPSR Nellore district of Andhra Pradesh.

The drug falls under the purview of price control regulations outlined in the Drugs (Prices Control) Order, 2013. “The pricing of the product is expected to adhere to the ‘Ceiling Price’ determined by the National Pharmaceutical Pricing Authority (NPPA), a body under the Government of India,” the statement added.

“The firm, in this case, was found to overprice the product, charging an excess of Rs 832 for one vial. This action is a clear violation of the Drugs (Prices Control) Order, 2013,” the statement added.

Related Posts

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care